Chemo-radiotherapy after neoadjuvant chemotherapy and radical hysterectomy in women with stage IB-IIB cervical cancer: Do we need to change the therapeutic approach? A cohort study
It can be concluded that a significant percentage of patients who are candidates for NACT followed by radical hysterectomy would require another modality of treatment, which is chemoradiotherapy; therefore, it is recommended that by conducting prospective studies, in addition to investigating this issue, the choice of the first method of patient treatment in these stages should be reconsidered so that patients do not suffer from two treatments and related complications, and undergo chemoradiotherapy from the beginning.
Authors
- Somayeh Nikfar
- Setareh Akhavan (ORCID: https://orcid.org/0000-0001-9338-3861)
- Ramin Parvizrad (ORCID: https://orcid.org/0000-0002-8225-4877)
- Shahrzad Sheikhhasani
- Amir Almasi‐Hashiani (ORCID: https://orcid.org/0000-0003-4434-561X)
- Narges Zamani (ORCID: https://orcid.org/0000-0002-9128-7224)
- Azam Sadat Mousavi
Institutions
- Arak University of Medical Sciences (IR)
- Imam Khomeini Hospital (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Surgery in Practice and Science
- Published
- 2025-04-28
- DOI
- https://doi.org/10.1016/j.sipas.2025.100284
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Tehran University of Medical Sciences and Health Services